Evidence map›Paper›PMID 26019615›Full record

ArticleBiotechnology, biotechnological equipment2015

Induction of resistance to potato virus Y strain NTN in potato plants through RNAi.

Nikolay Petrov, Mariya Stoyanova, Rayna Andonova, Atanaska Teneva

Open access · goldAbstract read
In one paragraph

Article in Biotechnology, biotechnological equipment, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. RNA silencing: the future potential strategy for engineering virus resistance in plants.Physiology and molecular biology of plants : an international journal of functional plant biology · 2025
    Review
  3. Article
  4. SilencingPotato research · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nikolay PetrovDepartment of Plant Protection, Institute of Soil Science, Agro Technologies and Plant Protection "N. Pushkarov" , Sofia , Bulgaria.
Mariya StoyanovaDepartment of Plant Protection, Institute of Soil Science, Agro Technologies and Plant Protection "N. Pushkarov" , Sofia , Bulgaria.
Rayna AndonovaDepartment of Plant Protection, Faculty of Agronomy, University of Forestry , Sofia , Bulgaria.
Atanaska TenevaDepartment of Genetics and Breeding of Agricultural Crops, Faculty of Agronomy, University of Forestry , Sofia , Bulgaria.
University of Forestry · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potato viruses cause enormous economic loss in agriculture production. Potatoes can be infected by a number of different viruses that affect negatively the harvest and the tuber quality. Direct and effective drugs against plant virus diseases are still not available and control is only applied as agricultural measures and pesticides against virus vectors. Potato virus Y (PVY) is transmitted by aphids in non-persistent manner and on that account using insecticides to prevent spread of the infection is useless. Breeding of resistant plant cultivars proved to be not always a solution of the problem because of the fast evolution of the virus strains and the constantly growing group of recombinants. In this study, we have proposed a new way of controlling the virus by blocking replication and transmission through the plant by RNAi-based vaccination of potato seedlings with specific to viral HC-Pro gene siRNAs. Thus, PVY replication is decreased without altering the valuable qualities of the sensitive to the virus potato cultivars like Agria.

Indexed as

potatoesPVYNTNRNAi

Identifiers

PMID26019615
PMCPMC4434039
OpenAlexW1990729103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.